COVID-19 Mitigation Products Market Overview 2025: Industry Report, Key Players - Pfizer, Qualaris Healthcare Solutions, Allscripts Healthcare Solutions, Agfa Healthcare, AbCellera, 3Scan

DataM Intelligence has published a new research report on "COVID-19 Mitigation Products Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/covid-19-mitigation-products-market?kb

Latest M&A Activity

While the healthcare sector M&A market is correcting, companies that expanded during the pandemic, like Thermo Fisher's acquisition of Qiagen and Hypera Pharma's purchase of Takeda's brands, remain stable and defy M&A delays caused by regulatory hurdles and global supply chain issues.​

Digital healthcare platforms supporting COVID-19 management and telehealth are also a focus of acquisition and investment by larger healthcare IT and services firms, aligning with sustained demand for remote services.

Key Players:

3M Company, Abbott, Agilent Technologies, Medtronic, Pfizer, Qualaris Healthcare Solutions, Allscripts Healthcare Solutions, Agfa Healthcare, AbCellera, 3Scan, Sanofi, Advenio Technosys, Siemens, Amara Health Analytics, Regeneron Pharmaceuticals, Avalon, Eli Lilly, Merck, Koninklijke Philips NV

Recent Product Launches and Procurement Insights

✦ New variants specific vaccines and bivalent boosters continue to launch, with Pfizer and BioNTech receiving updated FDA and EMA approvals and global rollout for Omicron BA.4/BA.5 adapted boosters in pediatric and adult populations.​

✦ Demand for personal protective equipment (PPE) surged significantly during the pandemic's emergency phase. Centralized procurement initiatives, like the UK's BSO PaLS, delivered nearly 500 million core PPE items, ensuring supply stability through increased strategic stockpiling and emergency contract awards.​

✦ Market demand has normalized but continues for sophisticated PPE types, rapid antigen tests, and digital contact tracing tools under ongoing pandemic management and endemic control

Growth Forecast Projected:

The Global COVID-19 Mitigation Products Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global COVID-19 Mitigation Products Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @: https://www.datamintelligence.com/buy-now-page?report=covid-19-mitigation-products-market?kb

Key Segments:

By Diagnostic Products and Services: (Serologic Test Kits, Robotic PCR Systems & Software, PCR Instrumentation & Software, Nose & Mouth Swabs, PCR Reagents & Consumables, Self-collection PCR Test Kits, X-Ray Procedures, Standoff Thermometry, Ultrasound Procedures, CT Procedures, PACS & Teleradiology, FDG-PET/CT Procedures & Wastewater Testing, Others)

By Intensive Care Products & Services: (Invasive Mechanical Ventilators, Noninvasive Ventilators, Portable Ventilators, Next Generation Ventilators, Kidney Dialysis, COVID-19 Homecare (HW, SW, Services), Surge Capacity Hospitals & ICUs, Extracorporeal Membrane Oxygenation Procedures, Others)

By Medical ICT: (E-Health, AI, Big Data & Deep Learning, Blockchain Technologies, Geo-Surveillance Systems & Services, Homecare IT, Others)

By Pharma Industry Products: (Vaccines, Therapeutic Drugs, Others)

By Personal & Protection Gear: (Medical Gloves, Medical Face Masks, Medical PPE Gowns, Hand & Surface Sanitizers, Medical Face Shields, PPE Sterilization: Systems & Consumables, Medical Eye Protection, Others)

By COVID-19 Related Manufacturing Plant: (Ventilators, Sorologic Test Kits, Self-collection PCR Test Kits, PCR Reagents, PCR Systems, Gloves, PPE Gowns, Face Masks, Face Shields, Melt-Blown PPE Fabric, Spun-Bond PPE Fabric, Nose & Mouth Swabs, Medical Glass & Other, R&D Equipment & Consumables, Others)

By End-User: (Hospitals, Emergency Medical Services (EMS), Clinical Labs, Research Bodies, Homecare & Nursing Homes, Clinics, Others)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Key Clinical Trials and Therapeutic Developments

✅ Phase 3 clinical trial data for Pfizer-BioNTech's LP.8.1-adapted mRNA COVID-19 vaccine (2025-2026 formula) demonstrated a robust immune response against multiple circulating SARS-CoV-2 sublineages, reinforcing regulatory approvals for updated booster formulations.​

✅ Ensitrelvir, an oral antiviral drug, showed potent antiviral activity in a randomized controlled phase 2 trial, presenting it as an effective alternative to Paxlovid. The trial focused on viral clearance rates in early symptomatic outpatient cases in Southeast Asia.​

✅ Tocilizumab (Actemra) and baricitinib (Olumiant) continue to have clinical evidence supporting mortality reduction and accelerated recovery among hospitalized COVID-19 patients with high oxygen requirements.​

✅ Novel intranasal and combination therapies are under investigation to enhance prophylactic and therapeutic efficacy with improved patient compliance in outpatient settings.​

Diagnostic Trials

✅ Several randomized clinical trials evaluated the accuracy of rapid antigen tests comparing self-collected nasal and throat swabs to healthcare worker-assisted sampling. These studies guide the optimization of rapid community-based testing strategies.​

✅ Ongoing studies explore integration of rapid antigen testing within telehealth workflows to improve early detection and containment in underserved populations.​

Research and Regulatory Updates

✅ WHO and CDC publish updated living guidelines for COVID-19 clinical management to incorporate new therapeutic evidence and optimize resource allocation globally.​

✅ Discussions are underway regarding the antigen composition of vaccines for December 2025 to better match circulating variants and boost population immunity in upcoming vaccine campaigns

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/covid-19-mitigation-products-market?kb

Reimbursement Trends

➠ Provider relief and reimbursement programs supported COVID-19 testing and vaccination efforts extensively in regions like the US under the American Rescue Plan and Provider Relief Fund. These programs continue to adapt with funding expiration timelines and evolving coverage criteria.​

➠ Several governments are encouraging equitable vaccine access with reduced or waived import duties and tax exemptions for critical COVID-19 medical supplies to support ongoing vaccination drives and treatments.

Get 2-Day Free Trial + 50% OFF DataM Subscription@: https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.